Flexion Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch FLXN and buy or sell other stocks, options, and ETFs commission-free!

About FLXN

Flexion Therapeutics advances drug candidates through clinical proof of concept and beyond, in partnership with pharmaceutical and biotechnology companies. By providing expertise and sharing risk, Flexion effectively expands the portfolios of its partners. 

CEO
Michael D. Clayman, MD
CEOMichael D. Clayman, MD
Employees
Employees
Headquarters
Burlington, Massachusetts
HeadquartersBurlington, Massachusetts
Founded
2007
Founded2007
Employees
Employees

FLXN Key Statistics

Market cap
458.93M
Market cap458.93M
Price-Earnings ratio
-4.76
Price-Earnings ratio-4.76
Dividend yield
Dividend yield
Average volume
3.03M
Average volume3.03M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$13.66
52 Week high$13.66
52 Week low
$4.30
52 Week low$4.30
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.